PETMED EXPRESS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that PETMED EXPRESS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Mar 31, 2020 | $74.29M | May 26, 2020 |
| FY2020 | Dec 31, 2019 | $59.92M | May 26, 2020 |
| FY2020 | Sep 30, 2019 | $69.94M | May 26, 2020 |
| FY2020 | Jun 30, 2019 | $79.99M | May 26, 2020 |
| FY2020 | Mar 31, 2019 | $64.57M | May 26, 2020 |
| FY2020 | Dec 31, 2018 | $60.07M | May 26, 2020 |
| FY2020 | Sep 30, 2018 | $71.40M | May 26, 2020 |
| FY2020 | Jun 30, 2018 | $87.39M | May 26, 2020 |
| FY2019 | Mar 31, 2018 | $67.32M | May 28, 2019 |
| FY2019 | Dec 31, 2017 | $60.11M | May 28, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $226.97M | Oct 14, 2025 |
| FY2025 | Dec 31, 2024 | $51.96M | Oct 14, 2025 |
| FY2025 | Sep 30, 2024 | $58.04M | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | $66.21M | Oct 14, 2025 |
| FY2025 | Mar 31, 2024 | $274.10M | Oct 14, 2025 |
| FY2025 | Dec 31, 2023 | $63.67M | Oct 14, 2025 |
| FY2025 | Sep 30, 2023 | $69.46M | Oct 14, 2025 |
| FY2025 | Jun 30, 2023 | $75.91M | Oct 14, 2025 |
| FY2025 | Mar 31, 2023 | $247.57M | Oct 14, 2025 |
| FY2025 | Dec 31, 2022 | $57.24M | Oct 14, 2025 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $69.14M | Oct 14, 2025 |
| FY2025 | Dec 31, 2024 | $16.13M | Oct 14, 2025 |
| FY2025 | Sep 30, 2024 | $18.77M | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | $19.04M | Oct 14, 2025 |
| FY2025 | Mar 31, 2024 | $84.77M | Oct 14, 2025 |
| FY2025 | Dec 31, 2023 | $19.42M | Oct 14, 2025 |
| FY2025 | Sep 30, 2023 | $21.26M | Oct 14, 2025 |
| FY2025 | Jun 30, 2023 | $25.00M | Oct 14, 2025 |
| FY2025 | Mar 31, 2023 | $76.50M | Oct 14, 2025 |
| FY2025 | Dec 31, 2022 | $16.57M | Oct 14, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($6.27M) | Oct 14, 2025 |
| FY2025 | Mar 31, 2024 | ($7.46M) | Oct 14, 2025 |
| FY2025 | Mar 31, 2023 | $5.14M | Oct 14, 2025 |
| FY2023 | Mar 31, 2022 | $5.54M | Apr 15, 2024 |
| FY2023 | Dec 31, 2021 | $3.82M | Apr 15, 2024 |
| FY2023 | Sep 30, 2021 | $5.77M | Apr 15, 2024 |
| FY2023 | Jun 30, 2021 | $3.58M | Apr 15, 2024 |
| FY2022 | Mar 31, 2021 | $6.81M | May 24, 2022 |
| FY2022 | Dec 31, 2020 | $7.61M | May 24, 2022 |
| FY2022 | Sep 30, 2020 | $8.41M | May 24, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($1.53M) | Oct 14, 2025 |
| FY2025 | Mar 31, 2024 | ($8.16M) | Oct 14, 2025 |
| FY2025 | Mar 31, 2023 | $6.05M | Oct 14, 2025 |
| FY2022 | Mar 31, 2022 | $7.06M | May 24, 2022 |
| FY2022 | Dec 31, 2021 | $5.15M | May 24, 2022 |
| FY2022 | Sep 30, 2021 | $8.09M | May 24, 2022 |
| FY2022 | Jun 30, 2021 | $5.42M | May 24, 2022 |
| FY2022 | Mar 31, 2021 | $8.39M | May 24, 2022 |
| FY2022 | Dec 31, 2020 | $9.29M | May 24, 2022 |
| FY2022 | Sep 30, 2020 | $10.47M | May 24, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $4.72M | Oct 14, 2025 |
| FY2025 | Mar 31, 2024 | $4.32M | Oct 14, 2025 |
| FY2025 | Mar 31, 2023 | $27.80M | Oct 14, 2025 |
| FY2024 | Mar 31, 2022 | $18.50M | Jun 14, 2024 |
| FY2023 | Mar 31, 2021 | $40.08M | Apr 15, 2024 |
| FY2022 | Mar 31, 2020 | $38.84M | May 24, 2022 |
| FY2021 | Mar 31, 2019 | $45.14M | May 25, 2021 |
| FY2020 | Mar 31, 2018 | $37.38M | May 26, 2020 |
| FY2019 | Mar 31, 2017 | $47.20M | May 28, 2019 |
| FY2018 | Mar 31, 2016 | $21.05M | May 29, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $5.11M | Oct 14, 2025 |
| FY2025 | Mar 31, 2024 | $4.51M | Oct 14, 2025 |
| FY2025 | Mar 31, 2023 | $5.26M | Oct 14, 2025 |
| FY2024 | Mar 31, 2022 | $1.75M | Jun 14, 2024 |
| FY2023 | Mar 31, 2021 | $2.43M | Apr 15, 2024 |
| FY2022 | Mar 31, 2020 | $2.31M | May 24, 2022 |
| FY2021 | Mar 31, 2019 | $620.0K | May 25, 2021 |
| FY2020 | Mar 31, 2018 | $703.0K | May 26, 2020 |
| FY2019 | Mar 31, 2017 | $10.60M | May 28, 2019 |
| FY2018 | Mar 31, 2016 | $20.13M | May 29, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $148.70M | Oct 14, 2025 |
| FY2025 | Mar 31, 2024 | $169.88M | Oct 14, 2025 |
| FY2024 | Mar 31, 2023 | $167.48M | Jun 14, 2024 |
| FY2023 | Mar 31, 2022 | $179.70M | Apr 15, 2024 |
| FY2022 | Mar 31, 2021 | $187.50M | May 24, 2022 |
| FY2021 | Mar 31, 2020 | $155.32M | May 25, 2021 |
| FY2020 | Mar 31, 2019 | $154.43M | May 26, 2020 |
| FY2019 | Mar 31, 2018 | $134.84M | May 28, 2019 |
| FY2018 | Mar 31, 2017 | $112.81M | May 29, 2018 |
| FY2017 | Mar 31, 2016 | $90.28M | May 23, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $63.57M | Oct 14, 2025 |
| FY2025 | Mar 31, 2024 | $73.15M | Oct 14, 2025 |
| FY2024 | Mar 31, 2023 | $57.51M | Jun 14, 2024 |
| FY2023 | Mar 31, 2022 | $56.25M | Apr 15, 2024 |
| FY2022 | Mar 31, 2021 | $46.22M | May 24, 2022 |
| FY2021 | Mar 31, 2020 | $25.31M | May 25, 2021 |
| FY2020 | Mar 31, 2019 | $19.75M | May 26, 2020 |
| FY2019 | Mar 31, 2018 | $19.11M | May 28, 2019 |
| FY2018 | Mar 31, 2017 | $19.44M | May 29, 2018 |
| FY2017 | Mar 31, 2016 | $7.08M | May 23, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $85.13M | Oct 14, 2025 |
| FY2025 | Mar 31, 2024 | $96.73M | Oct 14, 2025 |
| FY2025 | Mar 31, 2023 | $109.97M | Oct 14, 2025 |
| FY2025 | Mar 31, 2022 | $123.45M | Oct 14, 2025 |
| FY2024 | Mar 31, 2021 | $124.93M | Jun 14, 2024 |
| FY2023 | Mar 31, 2020 | $120.34M | Apr 15, 2024 |
| FY2022 | Mar 31, 2019 | $134.68M | May 24, 2022 |
| FY2021 | Mar 31, 2018 | $115.73M | May 25, 2021 |
| FY2020 | Mar 31, 2017 | $93.37M | May 26, 2020 |
| FY2019 | Mar 31, 2016 | $83.20M | May 28, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $26.66M | Oct 14, 2025 |
| FY2025 | Mar 31, 2024 | $26.66M | Oct 14, 2025 |
| FY2024 | Mar 31, 2023 | $0 | Jun 14, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $66.54M | Oct 14, 2025 |
| FY2025 | Mar 31, 2024 | $71.56M | Oct 14, 2025 |
| FY2024 | Mar 31, 2023 | $91.66M | Jun 14, 2024 |
| FY2023 | Mar 31, 2022 | $111.76M | Apr 15, 2024 |
| FY2023 | Dec 31, 2021 | $112.51M | Apr 15, 2024 |
| FY2023 | Sep 30, 2021 | $114.97M | Apr 15, 2024 |
| FY2023 | Jun 30, 2021 | $115.29M | Apr 15, 2024 |
| FY2022 | Mar 31, 2021 | $134.14M | May 24, 2022 |
| FY2021 | Mar 31, 2020 | $126.18M | May 25, 2021 |
| FY2020 | Mar 31, 2019 | $122.17M | May 26, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $54.72M | Oct 14, 2025 |
| FY2025 | Mar 31, 2024 | $55.30M | Oct 14, 2025 |
| FY2024 | Mar 31, 2023 | $104.09M | Jun 14, 2024 |
| FY2023 | Mar 31, 2022 | $111.08M | Apr 15, 2024 |
| FY2022 | Mar 31, 2021 | $118.72M | May 24, 2022 |
| FY2021 | Mar 31, 2020 | $103.76M | May 25, 2021 |
| FY2020 | Mar 31, 2019 | $100.53M | May 26, 2020 |
| FY2020 | Mar 31, 2018 | $77.94M | May 26, 2020 |
| FY2020 | Mar 31, 2017 | $58.73M | May 26, 2020 |
| FY2019 | Mar 31, 2016 | $37.64M | May 28, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Oct 14, 2025 |
| FY2025 | Mar 31, 2024 | 0 | Oct 14, 2025 |
| FY2025 | Mar 31, 2023 | 0 | Oct 14, 2025 |
| FY2024 | Mar 31, 2022 | 0 | Jun 14, 2024 |
| FY2023 | Mar 31, 2021 | 1 | Apr 15, 2024 |
| FY2022 | Mar 31, 2020 | 1 | May 24, 2022 |
| FY2021 | Mar 31, 2019 | 1 | May 25, 2021 |
| FY2020 | Mar 31, 2018 | 1 | May 26, 2020 |
| FY2019 | Mar 31, 2017 | 1 | May 28, 2019 |
| FY2018 | Mar 31, 2016 | 1 | May 29, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Oct 14, 2025 |
| FY2025 | Mar 31, 2024 | 0 | Oct 14, 2025 |
| FY2025 | Mar 31, 2023 | 0 | Oct 14, 2025 |
| FY2022 | Mar 31, 2022 | 0 | May 24, 2022 |
| FY2022 | Dec 31, 2021 | 0 | May 24, 2022 |
| FY2022 | Sep 30, 2021 | 0 | May 24, 2022 |
| FY2022 | Jun 30, 2021 | 0 | May 24, 2022 |
| FY2022 | Mar 31, 2021 | 0 | May 24, 2022 |
| FY2022 | Dec 31, 2020 | 0 | May 24, 2022 |
| FY2022 | Sep 30, 2020 | 0 | May 24, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 20.66M | Oct 14, 2025 |
| FY2025 | Mar 31, 2024 | 21.15M | Oct 14, 2025 |
| FY2024 | Mar 31, 2023 | 21.08M | Jun 14, 2024 |
| FY2023 | Mar 31, 2022 | 20.98M | Apr 15, 2024 |
| FY2022 | Mar 31, 2021 | 20.27M | May 24, 2022 |
| FY2021 | Mar 31, 2020 | 20.17M | May 25, 2021 |
| FY2020 | Mar 31, 2019 | 20.67M | May 26, 2020 |
| FY2019 | Mar 31, 2018 | 20.60M | May 28, 2019 |
| FY2018 | Mar 31, 2017 | 20.53M | May 29, 2018 |
| FY2017 | Mar 31, 2016 | 20.45M | May 23, 2017 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $181.0K | Oct 14, 2025 |
| FY2025 | Mar 31, 2024 | $12.44M | Oct 14, 2025 |
| FY2025 | Sep 30, 2023 | $6.34M | Oct 14, 2025 |
| FY2025 | Jun 30, 2023 | $6.35M | Oct 14, 2025 |
| FY2025 | Mar 31, 2023 | $24.54M | Oct 14, 2025 |
| FY2024 | Mar 31, 2022 | $24.38M | Jun 14, 2024 |
| FY2023 | Mar 31, 2021 | $22.69M | Apr 15, 2024 |
| FY2022 | Mar 31, 2020 | $21.80M | May 24, 2022 |
| FY2021 | Mar 31, 2019 | $21.93M | May 25, 2021 |
| FY2020 | Mar 31, 2018 | $17.47M | May 26, 2020 |